IPA Best of Health Awards – results
July 1, 2011Medical Communications Best of Health, IPA, awards, medical communications news
Langland and McCann Healthcare Sydney took home the highly coveted ‘Best of Show’ awards at the 2011 IPA Best of …
Almirall appoints new general manager for Germany
July 1, 2011Research and Development, Sales and Marketing Almirall, appointment, research and development, sales and marketing
Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …
Talentmark appoints Mark Johnson
June 30, 2011Business Services appointment, business services
Mark Johnson has joined London-based life science recruitment company Talentmark as a managing consultant. For the past eight years Mark …
AstraZeneca signs cancer drug discovery collaboration
June 30, 2011Research and Development AstraZeneca, PTC Therapeutics
AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …
FDA advisers reject Avastin appeal
June 30, 2011Sales and Marketing FDA, avastin
An FDA advisory panel has refused to back Roche’s Avastin in advanced breast cancer after ruling it neither safe nor …
The growing role of regulatory affairs
June 30, 2011Business Services, Research and Development, Sales and Marketing regulatory affairs, topra
Some years ago, regulatory affairs (RA) was seen by some as merely a ‘front office’ function, providing a necessary interface …
Grindeks opens API plant in Latvia
June 30, 2011Manufacturing and Production Grindeks, pharma manufacturing news
Latvian pharmaceutical company Grindeks has opened a new active pharmaceutical ingredient (API) manufacturing plant that it predicts will add around …
Tarceva fails to win NICE backing
June 30, 2011Sales and Marketing NICE, Tarceva
NICE has decided not to recommend Roche’s Tarceva because of uncertainty over how long the lung cancer drug can extend …
GSK welcomes outside researchers to its ‘open lab’
June 29, 2011Research and Development GSK, TB, academic alliance, malaria, open lab
The first scientists from outside GlaxoSmithKline have started work at the manufacturer’s ‘open lab’ for diseases of the developing world …
Janssen to collaborate with Jubilant on neuroscience targets
June 29, 2011Manufacturing and Production, Research and Development Janssen, Jubilant, neuroscience research
Janssen is to team up with Indian pharma services company Jubilant Life Sciences on neuroscience drug discovery. Jubilant Discovery Services …
New medicine approvals slumped to record low in 2010
June 29, 2011Research and Development, Sales and Marketing drug sales, new drug approvals, research
There was a major slide in medicine approvals last year, compounding a difficult and ominous period for the industry. Only …
Introducing SHL Pharma: A Greener Approach
June 29, 2011Manufacturing and Production auto injector, autoinjector, automation, final assembly, final packaging
SHL Group is proud to introduce SHL Pharma, a facility built with a greener approach providing final assembly, labeling and …
Treatment flexibility will improve adherence in diabetes, study suggests
June 29, 2011Research and Development, Sales and Marketing diabetes, insulin
A third of patients with diabetes admit to regularly missing or not taking insulin treatment three days a month, according …
Greek debt hits pharma deliveries
June 29, 2011Sales and Marketing Greece
The debt crisis afflicting Greece is starting to affect the country’s hospitals as pharma companies refuse to deliver drugs. Roche …
Regulators back Novartis’ Votubia
June 28, 2011Sales and Marketing Novartis, Votubia, everolimus
Novartis’ drug Votubia has been recommended by regulators to treat a disease for which the only current option in Europe …
BMA warns of ‘slash and burn’ health service cuts
June 28, 2011BMA, NHS reforms
The BMA has hit out against reckless cuts to health service budgets and a ‘phoney war’ on NHS pensions. In …
Shire gets green light for second Replagal facility
June 28, 2011Manufacturing and Production Replagal, Shire, Vpriv, pharma manufacturing news
The European Medicines Agency has approved a second manufacturing facility in the USA for Shire’s Fabry disease treatment Replagal. Shire’s …
GlaxoSmithKline fined $41m for manufacturing failings
June 28, 2011Manufacturing and Production GSK, pharma manufacturing news
GlaxoSmithKline has agreed to pay almost $41 million to dozens of US states in a lawsuit focusing on alleged substandard …
Pharma manufacturing news in brief
June 28, 2011Manufacturing and Production pharma manufacturing news
Abbott delays closure of Canadian facility, West Pharma starts a new build in China, plus updates from Vetter, Pharmadule and …
Sanofi appoints Peter Guenter senior VP, Europe
June 28, 2011Manufacturing and Production, Research and Development, Sales and Marketing appointment, manufacturing and production, research and development, sales and marketing
Sanofi has promoted Peter Guenter to senior vice president, Europe, with effect from 15 July. He is currently general manager …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
